CD274 and esophageal squamous cell carcinoma: firstly conducted a prospective PALACE-1 trial (42) that included 20 resectable ESCC patients, regardless of PDL-1 status, who received a preoperative PPCT pattern, and concluded that PPCT-related AEs (any grade) were similar to nCRT.